About CHS (NASDAQ:CHSCL)
CHS Inc. is an integrated agricultural company, providing grain, foods and energy resources to businesses and consumers on a global basis. The Company's segments include Energy, Ag, Nitrogen Production, Foods, and Corporate and Other. The Energy segment derives its revenues through refining, wholesaling and retailing of petroleum products. The Company's Ag segment includes its grain marketing, country operations, crop nutrients, processing and food ingredients, and renewable fuels businesses. The Nitrogen production segment consists equity method investment in CF Industries Nitrogen, LLC. The Food segment consists its equity method investment in Ventura Foods, LLC. The corporate and other segment includes wheat milling operations, as well as business solutions operations consisting of commodities hedging, insurance and financial services related to crop production. Its businesses primarily include financing, insurance, hedging and other service activities related to crop production.
Industry, Sector and Symbol:
- Industry: Flour Milling
- Sub-Industry: N/A
- Sector: N/A
- Symbol: NASDAQ:CHSCL
- CUSIP: N/A
- Web: www.chsinc.com
- Net Margins: -0.54%
- Return on Equity: -3.21%
- Return on Assets: -1.03%
- Outstanding Shares: 20,700,000
Frequently Asked Questions for CHS (NASDAQ:CHSCL)
What is CHS's stock symbol?
CHS trades on the NASDAQ under the ticker symbol "CHSCL."
How often does CHS pay dividends? What is the dividend yield for CHS?
CHS declared a quarterly dividend on Friday, December 2nd. Investors of record on Thursday, December 15th will be given a dividend of $0.4688 per share on Friday, December 30th. This represents a $1.88 annualized dividend and a dividend yield of 6.64%. The ex-dividend date is Tuesday, December 13th. View CHS's Dividend History.
Who are some of CHS's key competitors?
Some companies that are related to CHS include NCS Multistage Holdings (NCSM), Connecticut Water Service (CTWS), American Outdoor Brands Corporation (AOBC), SMART Global Holdings (SGH), Akebia Therapeutics (AKBA), QAD (QADA), NeoGenomics (NEO), The First of Long Island Corporation (FLIC), Abeona Therapeutics (ABEO), Intellia Therapeutics (NTLA), Alder BioPharmaceuticals (ALDR), New York Mortgage Trust (NYMT), Middlesex Water Company (MSEX), PC Connection (CNXN), Assembly Biosciences (ASMB), MacroGenics (MGNX), Johnson Outdoors (JOUT) and American Railcar Industries (ARII).
Who are CHS's key executives?
CHS's management team includes the folowing people:
- Jay D. Debertin, President, Chief Executive Officer (Age 56)
- Clinton J. Blew, Second Vice Chairman of the Board (Age 39)
- Daniel Schurr, First Independent Vice Chairman of the Board (Age 51)
- Timothy Skidmore, Chief Financial Officer, Executive Vice President (Age 55)
- Shirley Cunningham, Chief Operating Officer, Executive Vice President - Ag Business and Enterprise Strategy (Age 56)
- James Matthew Zappa, Executive Vice President, General Counsel (Age 52)
- Lynden E. Johnson, Executive Vice President - CHS Country Operations (Age 56)
- Lisa A. Zell, Executive Vice President - Business Solutions (Age 48)
- David Johnsrud, Treasurer, Secretary, Director (Age 62)
- Donald Anthony, Assistant Secretary, Assistant Treasurer, Director (Age 66)
Who owns CHS stock?
CHS's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Massey Quick Simon & CO. LLC (0.04%). Company insiders that own CHS stock include Steve Brian Riegel and Timothy N Skidmore. View Institutional Ownership Trends for CHS.
Who bought CHS stock? Who is buying CHS stock?
CHS's stock was acquired by a variety of institutional investors in the last quarter, including Massey Quick Simon & CO. LLC. Company insiders that have bought CHS stock in the last two years include Steve Brian Riegel and Timothy N Skidmore. View Insider Buying and Selling for CHS.
How do I buy CHS stock?
Shares of CHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CHS's stock price today?
One share of CHS stock can currently be purchased for approximately $28.23.
How big of a company is CHS?
CHS has a market capitalization of $367.86 million.
How can I contact CHS?
CHS's mailing address is 5500 Cenex Dr, INVER GROVE HEIGHTS, MN 55077-1721, United States. The company can be reached via phone at +1-651-3556000.
MarketBeat Community Rating for CHS (NASDAQ CHSCL)MarketBeat's community ratings are surveys of what our community members think about CHS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for CHS (NASDAQ:CHSCL) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for CHS (NASDAQ:CHSCL)
Analysts' Ratings History for CHS (NASDAQ:CHSCL)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for CHS (NASDAQ:CHSCL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for CHS (NASDAQ:CHSCL)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for CHS (NASDAQ CHSCL)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for CHS (NASDAQ CHSCL)
Insider Trades by Quarter for CHS (NASDAQ CHSCL)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/18/2017||Timothy N Skidmore||VP||Buy||3,161||$27.66||$87,433.26|| |
|11/17/2016||Steve Brian Riegel||Director||Buy||40||$28.67||$1,146.80|| |
Latest Headlines for CHS (NASDAQ CHSCL)
Financials are not available for this stock.
CHS (NASDAQ CHSCL) Chart for Tuesday, November, 21, 2017